These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 2684395
21. [Inhibition of cell proliferation and C-myc cancer protein expression in human colon adenocarcinoma cell line HT29 with VIP-131I-ASON]. Ou X, Tan T, Li Y. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1096-100. PubMed ID: 17121362 [Abstract] [Full Text] [Related]
23. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells. Sallot M, Lascombe I, Bermont L, Jouvenot M. Anticancer Res; 1997 Oct; 17(5A):3499-504. PubMed ID: 9413194 [Abstract] [Full Text] [Related]
26. Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cells. Wang XH, Whyzmuzis CA, An S, Chen Y, Wu JM, Schneidau TA, Mallouh C, Tazaki H. Biochem Mol Biol Int; 1994 Aug; 34(1):47-53. PubMed ID: 7849624 [Abstract] [Full Text] [Related]
27. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Chen HW, Huang HC. Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770 [Abstract] [Full Text] [Related]
29. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation. Ben-Baruch N, Reinhold WC, Alexandrova N, Ichinose I, Blake M, Trepel JB, Zajac-Kaye M. Mol Pharmacol; 1994 Jul; 46(1):73-8. PubMed ID: 8058059 [Abstract] [Full Text] [Related]
30. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ. Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [Abstract] [Full Text] [Related]
31. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions. Guo YS, Jin GF, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC. J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387 [Abstract] [Full Text] [Related]
33. [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6]. Baghdiguian S, Pichon J, Marvaldi J, Fantini J. Bull Cancer; 1991 Aug; 78(9):807-17. PubMed ID: 1751832 [Abstract] [Full Text] [Related]
34. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression. Habel ME, Lemieux R, Jung D. J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060 [Abstract] [Full Text] [Related]
37. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc. Rawson C, Shirahata S, Collodi P, Natsuno T, Barnes D. Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405 [Abstract] [Full Text] [Related]
38. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro. Suchy BK, Sarafoff M, Kerler R, Rabes HM. Cancer Res; 1989 Dec 01; 49(23):6781-7. PubMed ID: 2684400 [Abstract] [Full Text] [Related]
39. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression. Charollais RH, Mester J. J Cell Physiol; 1988 Dec 01; 137(3):559-64. PubMed ID: 3142887 [Abstract] [Full Text] [Related]
40. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line. Yang KP, Castillo SG, Nguyen CV, Hickey RC, Samaan NA. Anticancer Res; 1990 Dec 01; 10(1):189-92. PubMed ID: 2185686 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]